24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
14/12/2018
The Open Innovation Forum matches business challenges to academic solutions
07/12/2018
2017 BioCat report: The best of the Bioregion of Catalonia
30/11/2018
Barcelona Synchrotron Park’s Commitment to Sustainable Growth
23/11/2018
Astronomers led by IEEC reveal a cold super-Earth around Barnard’s star
16/11/2018
CRAG’s Researchers discover how to generate plants with enhanced drought resistance
08/11/2018
The Barcelona manifesto: for a city-led science and technology diplomacy